From August 21, 2023 to November 24, 2023, the company has repurchased 618,077 shares, representing 0.15% for CNY 20.01 million. With this, the company has completed the repurchase of 618,077 shares, representing 0.15% for CNY 20.01 million under the buyback announced on August 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.35 CNY | +1.50% |
|
+8.53% | -36.45% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.45% | 1.1B | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 688105 Stock
- News Nanjing Vazyme Biotech Co.,Ltd
- Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.